Ischemic stroke is one of the leading causes of death and disability. Ischemia triggers a
cascade of events leading to cell death and cerebral infarction. Mesenchymal stem cell …

Stroke, a global disease with a high disability rate, has limited options for functional
rehabilitation and results in an adverse impact on patients' lives. In recent years …

Stroke, the most prevalent cerebrovascular disease, causes serious loss of neurological
function and is the leading cause of morbidity and mortality worldwide. Despite advances in …

Ischemic stroke (IS) is a serious cerebrovascular disease with high morbidity and disability
worldwide. Despite the great efforts that have been made, the prognosis of patients with IS …

Abstract Cerebral Ischemic Stroke (CIS) has become a hot issue in medical research
because of the diversity of risk factors and the uncertainty of prognosis. In the field of …

Stroke is the second main cause of morbidity and mortality worldwide. The rationale for the
use of mesenchymal stem cells (MSCs) in stroke is based on the capacity of MSCs to …

Stroke is the most common neurological cause of morbidity and mortality in industrialized
countries, afflicting 15 million people every year. The numbers are expected to increase …

Due to aging of the world's population, stroke has become increasingly prevalent, leading to
a rise in socioeconomic burden. In the recent past, stroke research and treatment have …

Ischemic stroke is one of the most common causes of death. A brain that has suffered a
stroke is significantly damaged due to the transient interruption of blood supply. Stroke …

Cerebral ischemia is a major cause of morbidity and mortality in the aged population, as well
as a tremendous burden on the healthcare system. Despite timely treatment with …